David P. Hesson
Directeur/Bestuurslid bij GPC Biotech, Inc.
Oorsprong van het eerstegraads netwerk van David P. Hesson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.
2
| Subsidiary | Drugstore Chains | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David P. Hesson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University College London | College/University | Undergraduate Degree | |
| University of London | College/University | Doctorate Degree | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| Prosalix GmbH | Chief Executive Officer | ||
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Chief Executive Officer | |
| TRANSGENE | Biotechnology | Public Communications Contact |
Statistieken
Internationaal
| Duitsland | 8 |
| Verenigd Koninkrijk | 3 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
| Finance | 2 |
Operationeel
| Chief Executive Officer | 4 |
| Founder | 3 |
| Public Communications Contact | 2 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Sebastian A. Meier-Ewert | 9 |
| Laurie Doyle | 3 |
- Beurs
- Insiders
- David P. Hesson
- Bedrijfsconnecties
